SEARCH

SEARCH BY CITATION

References

  • 1
    BousquetJ, LockeyR, MallingHJ (eds). World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;53(Suppl. 44):2027.
  • 2
    Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54: 10221041.
  • 3
    Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87(Suppl. 1):4755.
  • 4
    Kagi MK, Wutrich B. Different methods of local allergen immunotherapy. Allergy 2002;57: 379388.
  • 5
    Canonica GW, Passalacqua G. Noninjection routes of immunotherapy. J Allergy Clin Immunol 2003;111: 437448.
  • 6
    Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis (Cochrane review). Cochrane Database Syst Rev 2003;2: CD002893.
  • 7
    Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in children. Allergy 1999;54: 11101113.
  • 8
    Lombardi C, Gargioni S, Melchiorre A, Tiri A, Falagiani P, Canonica GW et al. Safety of sublingual immunotherapy in adults: a post marketing surveillance study. Allergy 2001;56: 889892.
  • 9
    Andre’ C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121: 229234.
  • 10
    BousquetJ, VanCauwenbergeP (editors). Allergic rhinits and its impact on asthma. J Allergy Clin Immunol 2001;107(suppl.):240245.
  • 11
    Malling HJ. Allergen-specific immunotherapy in allergic rhinitis. Curr Opin Allergy Clin Immunol 2001;1: 4346.
  • 12
    Des-Roches A, Paradis L, Ménardo J-L, Bouges S, Daurés J-P, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitisations in children. J Allergy Clin Immunol 1997;99: 450453.
  • 13
    Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109: 251256.
  • 14
    NIH. Global initiative for asthma: guidelines for the diagnosis and management of asthma. NIH publication 97-4051, 1997.
  • 15
    Dreborg S, Frew A. Position paper: allergen standardization and skin tests. Allergy 1993;48(Suppl. 14):4982.
  • 16
    Hargreave FE, Ryan G, Thomson NC. Bronchial responsiveness to histamine and methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981;68: 347355.
  • 17
    Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD et al. Airway responsiveness. Standardized challenge tests with pharmacological, physical and sensitizing stimuli. Eur Resp J 1993;6: 5358.
  • 18
    Ciprandi G, Ricca V, Landi M, Passalacqua G, Bagnasco M, Canonica GW. Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge. Int Arch Allergy Immunol 1998;115: 157161.
  • 19
    Sokal RR, Rohlf FJ. Biometry. The principles and practice of statistics in biological research, 3rd edn. New York: WH Freeman & C, 1995.
  • 20
    Good P. Permutation tests: a practical guide to resampling methods for testing hypotheses, 2nd edn. New York: Springer Verlag, 2002.
  • 21
    Siegel S. Castellan NJ. Nonparametric statistics for the behavioral sciences, 2nd edn. New York: Mc Graw-Hill, 1998.
  • 22
    SPSS Inc. SPSS Advanced Models 9.0. Chicago: SOSS Inc, 1999: 497.
  • 23
    Lima MT, Wilson D, Pitkin L, Roberts A, Nouri-Aria K, Jacobson M et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002;32: 507514.
  • 24
    Passalacqua G, Albano M, Fregonese L, Mela GS, Canonica GW. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis. Lancet 1998;351: 629632.
  • 25
    Passalacqua G, Albano M, Riccio AM, Fregonese L, Puccinelli P, Permiani S et al. Clinical and immunological effects of a rush sublingual immunotherapy to parietaria species: a double blind placebo controlled trial. J Allergy Clin Immunol 1999;104: 964968.
  • 26
    Pajno G, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31: 13921397.
  • 27
    Purello D'Ambrosio F, Gangemi S, Merendino RA, Isola S, Puccinelli P, Parmiani S et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001;31: 12951302.
  • 28
    Frew AJ, Smith HE. Sublingual immunotherapy. J Allergy Clin Immunol 2001;107: 441444.
  • 29
    Lee SY, Kim SJ, Kwon SS, Kim YK, Moon HS, Song JS et al. Relation of airway reactivity and sensitivity with bronchial pathology in asthma. J Asthma 2002;39: 537544.
  • 30
    Lombardi C, Gargioni S, Venturi S, Zoccali P, Canonica GW, Passalacqua G. Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: effect on bronchial hyperreactivity. J Investig Allergol Clin Immunol 2001;11: 4145.
  • 31
    Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162: 20482052.
  • 32
    Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a ten year prospective study. Clin Exp Allergy 2003;33: 206210.
  • 33
    Alessandro F, Vincenzo ZG, Marco S, Marcello G, Enrica R. Compliance with pharmacologic prophylaxis and therapy in bronchial asthma. Ann Allergy 1994;73: 135140.
  • 34
    Kleijnen J, de Craen AJ, van Everdingen J, Krol L. Placebo effect in double blind clinical trials: a review of it interaction with medications. Lancet 1994;344: 13471349.